International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7927868
Original Article
Study of Cranial Ultrasound Findings in Neonates with Perinatal Risk Factors and It's Clinical Profile: A Descriptive Study
 ,
 ,
Published
May 12, 2023
Abstract
Background: Cranial ultrasonography is an easily accessible, well-accepted, first-line imaging modality that is widely used to screen preterm and high-risk infants for brain injury in the neonatal period. The present study was undertaken to determine the frequency of cranial ultrasound abnormalities in neonates in the first week of life and study the association between abnormal cranial ultrasound findings in neonates with perinatal risk factors in regard to the immediate clinical outcome in the form of mortality. Method: A total 150 neonates of both the genders from day 0 to day 28 of life with perinatal risk factors who had undergone cranial USG in first week of life were included in the study. Cranial ultrasound of these neonates was done. The cranial ultrasound findings, other demographic parameters, perinatal risk factors, clinical status and immediate outcome were noted. Results: The frequency of cranial ultrasound abnormalities in neonates in the first week of life was 28%. Among subjects with abnormal findings, all were studied in 24 to 72 hrs. of life. Pregnancy induced hypertension (47.83%) and prelabour rupture of membranes (34.78%) was high among subjects with abnormal cranial findings. Germinal matrix haemorrhage (GMH) was high among subjects with abnormal cranial findings (61.9%) with observed high perinatal risk factor being prematurity with low birth weight (1.5-2kgs) (59.5%). Among 42(28%) abnormal neonates, 35 (83.3%) were recovered and 6(14.28%) were discharged on request/DAMA and 1(2.38%) had mortality. Conclusion: The study concludes that cranial ultrasonography is critical as an investigatory modality in NICU and effectively documents morphology of brain damage.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1411 Views
54 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved